Literature DB >> 27889007

Nalmefene for alcohol dependence: a NICE decision?

Florian Naudet1, Niamh Fitzgerald2, Alain Braillon3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27889007     DOI： 10.1016/S2215-0366(16)30356-X

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  3 in total

1.  Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.

Authors:  Pablo Barrio; Lluisa Ortega; Josep Guardia; Carlos Roncero; Lara Yuguero; Antoni Gual
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

2.  Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Authors:  Alain Braillon; Francoise Taiebi; Amal Bernoussi
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 3.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.